RT Journal Article
SR Electronic
T1 A roadmap for implanting microelectrode arrays to evoke tactile sensations through intracortical microstimulation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.26.24306239
DO 10.1101/2024.04.26.24306239
A1 Downey, John E
A1 Schone, Hunter R
A1 Foldes, Stephen T
A1 Greenspon, Charles
A1 Liu, Fang
A1 Verbaarschot, Ceci
A1 Biro, Daniel
A1 Satzer, David
A1 Moon, Chan Hong
A1 Coffman, Brian A
A1 Youssofzadeh, Vahab
A1 Fields, Daryl
A1 Hobbs, Taylor G
A1 Okorokova, Elizaveta
A1 Tyler-Kabara, Elizabeth C
A1 Warnke, Peter C
A1 Gonzalez-Martinez, Jorge
A1 Hatsopoulos, Nicholas G
A1 Bensmaia, Sliman J
A1 Boninger, Michael L
A1 Gaunt, Robert A
A1 Collinger, Jennifer L
YR 2024
UL http://medrxiv.org/content/early/2024/04/28/2024.04.26.24306239.abstract
AB Intracortical microstimulation (ICMS) is a method for restoring sensation to people with paralysis as part of a bidirectional brain-computer interface to restore upper limb function. Evoking tactile sensations of the hand through ICMS requires precise targeting of implanted electrodes. Here we describe the presurgical imaging procedures used to generate functional maps of the hand area of the somatosensory cortex and subsequent planning that guided the implantation of intracortical microelectrode arrays. In five participants with cervical spinal cord injury, across two study locations, this procedure successfully enabled ICMS-evoked sensations localized to at least the first four digits of the hand. The imaging and planning procedures developed through this clinical trial provide a roadmap for other brain-computer interface studies to ensure successful placement of stimulation electrodes.Competing Interest StatementNH and RG served as consultants for Blackrock Neurotech, Inc, at the time of the study. RG is also on the scientific advisory board of Neurowired LLC. MB, JC, and RG received research funding from Blackrock Neurotech, Inc. though that funding did not support the work presented here. PW served as a consultant for Medtronic.Clinical TrialNCT01894802Funding StatementThis work was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health (NIH) under Award Numbers UH3 NS107714. Work at the University of Pittsburgh was developed with funding from the Defense Advanced Research Projects Agency's (DARPA, Arlington) Revolutionizing Prosthetics program (contract number N66001-10-C-4056).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Chicago IRB, University of Pittsburgh IRBI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.